6-159969361-C-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_000876.4(IGF2R):āc.115C>Gā(p.Gln39Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000173 in 1,294,430 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_000876.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IGF2R | NM_000876.4 | c.115C>G | p.Gln39Glu | missense_variant | 1/48 | ENST00000356956.6 | NP_000867.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IGF2R | ENST00000356956.6 | c.115C>G | p.Gln39Glu | missense_variant | 1/48 | 1 | NM_000876.4 | ENSP00000349437 | P1 | |
IGF2R | ENST00000677704.1 | c.115C>G | p.Gln39Glu | missense_variant, NMD_transcript_variant | 1/49 | ENSP00000503314 | ||||
IGF2R | ENST00000676781.1 | c.115C>G | p.Gln39Glu | missense_variant, NMD_transcript_variant | 1/49 | ENSP00000504419 |
Frequencies
GnomAD3 genomes AF: 0.0000659 AC: 10AN: 151798Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.000187 AC: 214AN: 1142632Hom.: 0 Cov.: 31 AF XY: 0.000191 AC XY: 106AN XY: 554252
GnomAD4 genome AF: 0.0000659 AC: 10AN: 151798Hom.: 0 Cov.: 32 AF XY: 0.0000809 AC XY: 6AN XY: 74134
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 26, 2023 | The c.115C>G (p.Q39E) alteration is located in exon 1 (coding exon 1) of the IGF2R gene. This alteration results from a C to G substitution at nucleotide position 115, causing the glutamine (Q) at amino acid position 39 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at